Mutations in ASXL1 and/or TET2 Identify a Subset with Worse Outcomes in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasms

被引：0

作者：

Xu, Mina ^{[1
]}

Thakkar, Devang ^{[2
]}

Panse, Gauri ^{[1
]}

Yan, Jiong ^{[3
,4
]}

Minden, Mark ^{[5
]}

Zandi, Sasan ^{[6
]}

Naresh, Kikkeri ^{[7
]}

Czader, Magdalena ^{[8
]}

Love, Cassandra ^{[2
]}

Happ, Lanie ^{[9
]}

Koff, Jean ^{[10
]}

Jaye, David ^{[11
]}

Michael, Churnetski ^{[10
]}

Arildsen, Mary Ann ^{[12
]}

Juskevicius, Ridas ^{[13
]}

Soliman, Dina ^{[14
]}

Louissaint, Abner ^{[15
]}

Mckinney, Matthew ^{[2
]}

Sojitra, Payal ^{[16
]}

Yin, C. Cameron ^{[17
]}

Ondrejka, Sarah ^{[18
]}

Tse, Eric ^{[19
]}

Dave, Sandeep ^{[2
]}

机构：

[1] Yale Univ, New Haven, CT USA

[2] Duke Univ, Durham, NC USA

[3] Univ Hlth Network, Lab Med Program, Dept Anat Pathol, Toronto, ON, Canada

[4] Univ Toronto, Toronto, ON, Canada

[5] Univ Hlth Network, Toronto, ON, Canada

[6] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada

[7] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA USA

[8] Indiana Univ, Indianapolis, IN USA

[9] Data Driven Biosci, Durham, NC USA

[10] Emory Univ, Atlanta, GA USA

[11] Emory Univ, Sch Med, Atlanta, GA USA

[12] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[13] Pathgroup, Nashville, TN USA

[14] Hamad Med Corp, Doha, Qatar

[15] Massachusetts Gen Hosp, Boston, MA 02114 USA

[16] Univ Med & Dent New Jersey, New Brunswick, NJ USA

[17] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[18] Cleveland Clin, Cleveland, OH USA

[19] Univ Hong Kong, Pokfulam, Hong Kong, Peoples R China

来源：

LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

1210

引用

页码：S1258 / S1259

页数：2

共 50 条

[1] Molecular Screening In Blastic Plasmacytoid Dendritic Cell Neoplasms Reveals Mutations In TET2 and ASXL1 In The Majority Of Patients
Kern, Wolfgang
Kuznia, Sabrina
Schnittger, Susanne
Haferlach, Claudia
Haferlach, Torsten
Kohlmann, Alexander
BLOOD, 2013, 122 (21)
[2] TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm
Beird, Hannah
Yin, C. Cameron
Khoury, Joseph D.
Pierce, Sherry
Abbas, Hussein A.
Zhao, Li
Skwarska, Anna
Qazilbash, Muzaffar
Konopleva, Marina
Futreal, P. Andrew
Pemmaraju, Naveen
BLOOD ADVANCES, 2023, 7 (10) : 2000 - 2003
[3] Biallelic TET2 mutations and canonical ASXL1 mutations are frequent and cooccur in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): An institutional experience and review of literature
Zhang, Xi
Hsi, Eric D.
Crane, Genevieve M.
Cheng, Yu-Wei
EJHAEM, 2023, 4 (01): : 236 - 240
[4] Role of TET2 and ASXL1 Mutations in the Pathogenesis of Myeloproliferative Neoplasms
Abdel-Wahab, Omar
Mu, Ayalew Tefferi
Levine, Ross L.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2012, 26 (05) : 1053 - +
[5] TET2 and ASXL1 Mutations in Leukemic Transformation of Chronic Myeloproliferative Neoplasms
Abdel-Wahab, Omar
Manshouri, Taghi
Patel, Jay
Harris, Kelly
Yao, Jin Juan
Hedvat, Cyrus V.
Heguy, Adriana
Bueso-Ramos, Carlos
Kantarjian, Hagop M.
Levine, Ross L.
Verstovsek, Srdan
BLOOD, 2009, 114 (22) : 1130 - 1131
[6] Mutations of ASXL1 and TET2 in aplastic anemia
Huang, Jinbo
Ge, Meili
Lu, Shihong
Shi, Jun
Li, Xingxin
Zhang, Jizhou
Wang, Min
Yu, Wei
Shao, Yingqi
Huang, Zhendong
Zhang, Jing
Nie, Neng
Zheng, Yizhou
HAEMATOLOGICA, 2015, 100 (05)
[7] Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations
Szpurka, Hadrian
Jankowska, Anna M.
Makishima, Hideki
Bodo, Juraj
Bejanyan, Nelli
Hsi, Eric D.
Sekeres, Mikkael A.
Maciejewski, Jaroslaw P.
LEUKEMIA RESEARCH, 2010, 34 (08) : 969 - 973
[8] DNMT3A, TET2, and ASXL1 (DTA) Mutations Are Associated with Thrombosis and Bleeding in Patients with Myeloproliferative Neoplasms
Haran, Arnon
Wasserstrom, Avital
Aumann, Shlomzion
Vainstein, Vladimir
Kazoom, Romi
Jelinek, Batia Roth
Arad, Ariela
Buchman, Noa
Shai, Ela
Kalish, Yossi
Gatt, Moshe E.
Zimran, Eran
BLOOD, 2024, 144 : 3189 - 3190
[9] TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm
Jardin, Fabrice
Ruminy, Philippe
Parmentier, Francoise
Troussard, Xavier
Vaida, Iona
Stamatoullas, Aspasia
Lepretre, Stephane
Penther, Dominique
Duval, Anne B.
Picquenot, Jean-Michel
Courville, Philippe
Capiod, Jean-Claude
Tilly, Herve
Bastard, Christian
Marolleau, Jean P.
BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 (03) : 413 - 416
[10] TET2, ASXL1, IDH1 AND IDH2 MUTATIONS IN NON-CML MYELOPROLIFERATIVE NEOPLASMS
Soyer, N. Akad
Kaymaz, B. Tezcanli
Ozkan, M. Comert
Aktan, C.
Sahin, F.
Kosova, B.
Saydam, G.
LEUKEMIA RESEARCH, 2014, 38 : S46 - S47

← 1 2 3 4 5 →